Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6518
    +0.0018 (+0.28%)
     
  • OIL

    82.94
    +0.13 (+0.16%)
     
  • GOLD

    2,330.20
    -8.20 (-0.35%)
     
  • Bitcoin AUD

    98,658.02
    -3,577.20 (-3.50%)
     
  • CMC Crypto 200

    1,390.95
    +8.38 (+0.61%)
     
  • AUD/EUR

    0.6077
    +0.0007 (+0.11%)
     
  • AUD/NZD

    1.0954
    +0.0012 (+0.11%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,232.09
    +30.82 (+0.18%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Teva to buy Auspex for $101/share in cash

Adam Reynolds | Bloomberg | Getty Images. Health-care stocks haven't gotten the green light many expected from Hillary Clinton's election loss.

Drugmaker Teva (Tel Aviv Stock Exchange: TEVA-IL)Pharmaceuticals said it would buy Auspex (NASDAQ: ASPX)for $101 per share in cash, or $3.5 billion in equity value.

Teva said the deal would add a portfolio of drugs for the treatment of central nervous system disorders.

Auspex shares closed Friday at $70.91.




More From CNBC